- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07820839
Digital Stimulation and Anxiety and Sleep Quality in Intensive Care Unit Patients
The Effect of Digital Visual and Auditory Stimulation on Anxiety and Sleep Quality in Patients Hospitalized in the Intensive Care Unit: A Randomized Controlled Trial
The aim of this study is to examine the effect of digital visual and auditory stimulation on anxiety and sleep quality in patients hospitalized in the intensive care unit (ICU).
The questions to be answered within the scope of the research are:
Does the application of digital visual and auditory stimulation to patients in intensive care units have a significant effect on anxiety levels? Does the application of digital visual and auditory stimulation to patients in intensive care units have a significant effect on sleep quality? Does the application of digital visual and auditory stimulation to patients in intensive care units have a combined effect on anxiety levels and sleep quality?
Participants will:
The patients will be divided into two groups: an intervention group and a control group. The intervention group will receive visual and auditory stimuli once a day, every morning for three days. Sleep quality and anxiety levels will be measured after the digital visual and auditory stimuli.
The control group will continue with routine intensive care unit follow-up treatments.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Esra Başer Akın
- Número de teléfono: +90 538 478 06 60
- Correo electrónico: esra_baser568@hotmail.com
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- 18 years and above
- Conscious [Glasgow Coma Scale(GCS)] ≥ 14)
- Not connected to mechanical ventilation or receiving non-invasive support
- Hearing and visual functions are sufficient
- No communication problems
- Able to answer questions correctly
- Not under sedation
- Expected to stay in the ICU for at least 48 hours
Exclusion Criteria:
- Having a hearing or visual impairment
- Being under sedation
- Having impaired consciousness
- Refusing to participate in the study
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention Group: Digital Visual and Auditory Stimulation
Patients in the intervention group will receive visual and auditory stimuli once a day, every morning for three days.
Visually, they will be shown landscape images on a tablet.
Simultaneously, they will listen to classical music (60-80 bpm) through headphones.
As a pre-test, patients in the intervention group will complete a questionnaire, the Richards-Campbell Sleep Scale, and the Hospital Anxiety and Depression Scale.
These scales will also be administered as a post-test on the third day.
|
Visually, they will be shown landscape images on a tablet.
Simultaneously, they will listen to classical music (60-80 bpm) through headphones.
|
|
Sin intervención: Control Group: Usual Care
Patients in the control group will also be administered the Richards-Campbell Sleep Scale (RCSQ) and the Hospital Anxiety and Depression Scale (HADS) at the beginning of the data collection process, at the same time as the intervention group.
Patients in the control group will not receive any intervention during the study; their routine intensive care treatment and care will continue.
The scales will be administered simultaneously with the intervention group at the end of the third day.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Richards-Campbell Sleep Questionnaire (RCSQ)
Periodo de tiempo: The sleep questionnaire will be administered upon admission to the intensive care unit on the first day of the study and at the end of the third day of the intervention.
|
The Richard-Campbell Sleep Scale (RCSS) is a scale developed by Richards in 1987 to assess the quality of nocturnal sleep in patients.
Adapted into Turkish by Özlü and Özer, and subsequently validated and its reliability studied, the scale consists of six items that evaluate the depth of nocturnal sleep, time to fall asleep, frequency of awakenings, duration of wakefulness, quality of sleep, and ambient noise level.
Each item is evaluated on a visual analog scale ranging from 0 to 100.
A score of "0-25" indicates very poor sleep, while a score of "76-100" indicates very good sleep.
As the scale score increases, the patients' sleep quality also improves.
The Cronbach's α value of the scale was determined to be 0.82.
|
The sleep questionnaire will be administered upon admission to the intensive care unit on the first day of the study and at the end of the third day of the intervention.
|
|
Hospital Anxiety and Depression Scale (HADS)
Periodo de tiempo: The scale will be administered as a first test during the initial interview at the beginning of the study and as a final test during the final interview at the end of the third day.
|
Developed by Zigmond and Snaith (1983) to determine a patient's risk of anxiety and depression, and to measure their level and severity, the scale's validity and reliability in Turkish were established by Aydemir et al. (1997).
The scale contains 14 questions in total, with odd numbers measuring anxiety and even numbers measuring depression.
The scale consists of two subscales: Anxiety (HAD-A) and Depression (HAD-D).
In the validity and reliability study, the cutoff score for HAD-A was found to be 10/11, and for HAD-D, 7/8.
Accordingly, scores above these points are considered at risk.
The scale is a four-point Likert type, with a total score ranging from 0 to 42.
|
The scale will be administered as a first test during the initial interview at the beginning of the study and as a final test during the final interview at the end of the third day.
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
Enlaces Útiles
- Karaman Özlü, Z., & Özer, N. (2015). Richard-Campbell Uyku Ölçeği geçerlilik ve güvenirlik çalışması. Türk Uyku Tıbbı Dergisi, 2(2), 29-32
- Aydemir, Ö., Güvenir, T., Küey, L., & Kültür, S. (1997). Hastane Anksiyete ve Depresyon Ölçeği Türkçe formunun geçerlilik ve güvenilirliği. Türk Psikiyatri Dergisi, 8(4), 280-287.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 12.08.2026-50534
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .